Enhancing preclinical drug discovery with artificial intelligence

被引：42
|
作者：
Vijayan, R. S. K. [1 ]
Kihlberg, Jan [2 ]
Cross, Jason B. [1 ]
Poongavanam, Vasanthanathan [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA
[2] Uppsala Univ, Dept Chem BMC, Uppsala, Sweden
来源：
DRUG DISCOVERY TODAY | 2022年 / 27卷 / 04期
关键词：
Artificial intelligence; Machine learning; Deep learning; Drug discovery; LIGAND BINDING-AFFINITY; ACCURATE PREDICTION; NEURAL-NETWORKS; DOCKING; COMPUTER; OPTIMIZATION; QUALITY; DESIGN; MODELS; GUIDE;
D O I：
10.1016/j.drudis.2021.11.023
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Artificial intelligence (AI) is becoming an integral part of drug discovery. It has the potential to deliver across the drug discovery and development value chain, starting from target identification and reaching through clinical development. In this review, we provide an overview of current AI technologies and a glimpse of how AI is reimagining preclinical drug discovery by highlighting examples where AI has made a real impact. Considering the excitement and hyperbole surrounding AI in drug discovery, we aim to present a realistic view by discussing both opportunities and challenges in adopting AI in drug discovery.
引用
收藏
页码：967 / 984
页数：18
相关论文
共 50 条
  • [31] Artificial intelligence for drug discovery: Resources, methods, and applications
    Chen, Wei
    Liu, Xuesong
    Zhang, Sanyin
    Chen, Shilin
    [J]. MOLECULAR THERAPY NUCLEIC ACIDS, 2023, 31 : 691 - 702
  • [32] Artificial intelligence approaches for rational drug design and discovery
    Duch, Wlodzislaw
    Swaminathan, Karthikeyan
    Meller, Jaroslaw
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (14) : 1497 - 1508
  • [33] Artificial intelligence in cancer target identification and drug discovery
    You, Yujie
    Lai, Xin
    Pan, Yi
    Zheng, Huiru
    Vera, Julio
    Liu, Suran
    Deng, Senyi
    Zhang, Le
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [34] Artificial intelligence for small molecule anticancer drug discovery
    Duo, Lihui
    Liu, Yu
    Ren, Jianfeng
    Tang, Bencan
    Hirst, Jonathan D.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (08) : 933 - 948
  • [35] Exploring Artificial Intelligence in Drug Discovery: A Comprehensive Review
    Rajneet Kaur Bijral
    Inderpal Singh
    Jatinder Manhas
    Vinod Sharma
    [J]. Archives of Computational Methods in Engineering, 2022, 29 : 2513 - 2529
  • [36] Artificial intelligence for dementia drug discovery and trials optimization
    Doherty, Thomas
    Yao, Zhi
    Khleifat, Ahmad A. l.
    Tantiangco, Hanz
    Tamburin, Stefano
    Albertyn, Chris
    Thakur, Lokendra
    Llewellyn, David J.
    Oxtoby, Neil P.
    Lourida, Ilianna
    Ranson, Janice M.
    Duce, James
    [J]. ALZHEIMERS & DEMENTIA, 2023, 19 (12) : 5922 - 5933
  • [37] Natural product drug discovery in the artificial intelligence era
    Saldivar-Gonzalez, F. I.
    Aldas-Bulos, V. D.
    Medina-Franco, J. L.
    Plisson, F.
    [J]. CHEMICAL SCIENCE, 2022, 13 (06) : 1526 - 1546
  • [38] Use of artificial intelligence to enhance phenotypic drug discovery
    Malandraki-Miller, Sophia
    Riley, Paul R.
    [J]. DRUG DISCOVERY TODAY, 2021, 26 (04) : 887 - 901
  • [39] Artificial intelligence and machine learning in drug discovery and development
    Patel V.
    Shah M.
    [J]. Intelligent Medicine, 2022, 2 (03): : 134 - 140
  • [40] The convergence of artificial intelligence and chemistry for improved drug discovery
    Green, Clive P.
    Engkvist, Ola
    Pairaudeau, Garry
    [J]. FUTURE MEDICINAL CHEMISTRY, 2018, 10 (22) : 2573 - 2576
12345